Bashaer Al Dhahwani
Phacoemulsification also called small incision surgery, is one of the most common type of cataract surgery performed with small incision with self-sealing, requiring one or even no sutures. Phacoemulsification has the advantage of more rapid visual recovery due to the small incision size, and decreased likelihood of suture-induced astigmatism. Endoscopic cyclophotocoagulation (ECP) is an emerging tool in the treatment of glaucoma, Endoscopic photoablation of ciliary processes was first described by Shields in 1985, The American Academy of Ophthalmology concluded in 2001 that ECP is safer than trans-scleral therapy and 10 years later many indications have been suggested for ECP, refractory glaucoma, paediatric glaucoma, aphakic glaucoma and severe corneal disease. In combined phacoemulsification with endoscopic cyclophotocoagulation (ECP), there are many studies which show that phacoemulsification associated with endoscopic cyclophoto-coagulation is safe and effective as a primary procedure for combined glaucoma and cataract. It resulted in lowering IOP and a greater reduction than glaucoma medications than cataract extraction alone in medically controlled OAG patients with visually significant cataract. As, in our literature search we did not find any study supporting the same research question. All studies about phacoemulsification with endoscopic cyclophotocoagulation (ECP) have been done under local or intracameral anesthesia.
